In the last trading session, 1.06 million shares of the Fortress Biotech Inc (NASDAQ:FBIO) were traded, and its beta was 1.68. Most recently the company’s share price was $2.25, and it changed around $0.2 or 9.76% from the last close, which brings the market valuation of the company to $61.96M. FBIO currently trades at a discount to its 52-week high of $4.43, offering almost -96.89% off that amount. The share price’s 52-week low was $1.36, which indicates that the current value has risen by an impressive 39.56% since then. We note from Fortress Biotech Inc’s average daily trading volume that its 10-day average is 0.79 million shares, with the 3-month average coming to 680.79K.
Fortress Biotech Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended FBIO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Fortress Biotech Inc (NASDAQ:FBIO) trade information
Instantly FBIO has showed a green trend with a performance of 9.76% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.32 on recent trading dayincreased the stock’s daily price by 3.02%. The company’s shares are currently down -25.25% year-to-date, but still down -2.17% over the last five days. On the other hand, Fortress Biotech Inc (NASDAQ:FBIO) is 30.81% up in the 30-day period. We can see from the shorts that 2.62 million shares have been sold at a short interest cover period of 4.57 day(s).
Fortress Biotech Inc (FBIO) estimates and forecasts
Fortress Biotech Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 14.80 percent over the past six months and at a 61.28% annual growth rate that is well above the industry average of 17.10%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 22.28%. Fortress Biotech Inc earnings are expected to increase by 58.60% in 2024, but the outlook is positive 25.50% per year for the next five years.
FBIO Dividends
Fortress Biotech Inc’s next quarterly earnings report is expected to be released in January.
Fortress Biotech Inc (NASDAQ:FBIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 21.21% of Fortress Biotech Inc shares, and 15.78% of them are in the hands of institutional investors. The stock currently has a share float of 20.03%.
